Healthcare Technology Report May 29, 2024

The U.S. FDA, Environmental Protection Agency, and Department of Agriculture have responded to President Biden’s call by unveiling a comprehensive plan to overhaul biotech regulations. Prompted by Executive Order 14081, issued in September 2022, the plan aims to modernize regulations surrounding the development and manufacture of biotech products, from industrial goods to CRISPR technologies. Stakeholder feedback, including input from industry groups and public commentary, has shaped the plan, highlighting the need for clarity, synchronization, and updates to existing regulations.

Future policy initiatives outlined in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Congress / White House, Govt Agencies, HHS, Pharma / Biotech, Regulations
Related Articles:
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More
Beyond National Health Expenditure Data: Three Things I Wish Were Better Measured

Share This Article